Amélie Lusque
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Lung Cancer Treatments and Mutations
- Advanced Breast Cancer Therapies
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 13
- HER2/EGFR in Cancer Research 5
-
- Advanced Breast Cancer Therapies 8
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Julien Mazières (5 shared papers)Isabelle Rouquette (2 shared papers)Nicolas Marie Guibert (2 shared papers)Gilles Favre (2 shared papers)Anne Pradines (2 shared papers)Thomas Filleron (17 shared papers)Myriam Delaunay (1 shared paper)Jean Mourlanette (1 shared paper)
- Journals
- Annals of Oncology (9 papers)British Journal of Cancer (3 papers)Clinical and Translational Radiation Oncology (2 papers)International Journal of Gynecological Cancer (2 papers)EMBO Molecular Medicine (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Amélie Lusque
66 papers receiving 3.3k citations
Amélie Lusque's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 579
- Genetics 156
- Radiology, Nuclear Medicine and Imaging 254
Countries citing papers authored by Amélie Lusque
This map shows the geographic impact of Amélie Lusque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Lusque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Lusque more than expected).
Fields of papers citing papers by Amélie Lusque
This network shows the impact of papers produced by Amélie Lusque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Lusque. The network helps show where Amélie Lusque may publish in the future.
Co-authors
The 25 scholars most cited alongside Amélie Lusque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry Hit paper breakdown → | 2019 | 1055 |
| 2 | 2017 | 337 | |
| 3 | Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial Hit paper breakdown → | 2023 | 294 |
| 4 | 2020 | 233 | |
| 5 | 2018 | 192 | |
| 6 | 2021 | 127 | |
| 7 | 2022 | 121 | |
| 8 | 2019 | 102 | |
| 9 | 2020 | 81 | |
| 10 | 2021 | 63 | |
| 11 | 2018 | 44 | |
| 12 | 2022 | 44 | |
| 13 | 2020 | 38 | |
| 14 | 2017 | 37 | |
| 15 | 2022 | 37 | |
| 16 | 2019 | 34 | |
| 17 | 2019 | 30 | |
| 18 | 2022 | 29 | |
| 19 | 2016 | 28 | |
| 20 | 2020 | 27 |
About Amélie Lusque
Amélie Lusque is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Otorhinolaryngology and Genetics, having authored 72 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (8 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers), Head and Neck Cancer Studies (5 papers), HER2/EGFR in Cancer Research (5 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (579 citations), Genetics (156 citations) and Radiology, Nuclear Medicine and Imaging (254 citations). Amélie Lusque has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Julien Mazières, Isabelle Rouquette, Nicolas Marie Guibert, Gilles Favre, Anne Pradines, Thomas Filleron, Myriam Delaunay, Jean Mourlanette, Nadia Boubekeur and Élodie Chantalat. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Clinical and Translational Radiation Oncology, International Journal of Gynecological Cancer and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.